We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Everest Group
EG
$15.2B
| $699K | 0.01% |
4,018
-5,880
| -59% | -$1.03M |
|
|
PRO
627
DELISTED
PROS Holdings
PRO
| $697K | 0.01% |
+28,199
| New | +$696K |
|
628
Analog Devices
ADI
$181B
| $690K | 0.01% |
+10,956
| New | +$621K |
|
629
Ironwood Pharmaceuticals
IRWD
$611M
| $690K | 0.01% |
+51,463
| New | +$675K |
|
630
Prothena Corp
PRTA
$458M
| $689K | 0.01% |
+18,070
| New | +$464K |
|
|
CY
631
DELISTED
Cypress Semiconductor
CY
| $689K | 0.01% |
+48,807
| New | +$723K |
|
|
ANDV
632
DELISTED
Andeavor
ANDV
| $685K | 0.01% |
7,509
-267,225
| -97% | -$22.4M |
|
|
WWE
633
DELISTED
World Wrestling Entertainment
WWE
| $681K | 0.01% |
+48,589
| New | +$690K |
|
|
CBM
634
DELISTED
Cambrex Corporation
CBM
| $679K | 0.01% |
+17,147
| New | +$507K |
|
635
Fair Isaac
FICO
$28.7B
| $677K | 0.01% |
+7,627
| New | +$614K |
|
636
Hecla Mining
HL
$10.2B
| $677K | 0.01% |
+227,200
| New | +$722K |
|
|
HDP
637
DELISTED
Hortonworks, Inc.
HDP
| $676K | 0.01% |
28,373
+15,949
| +128% | +$370K |
|
|
MIK
638
DELISTED
Michaels Stores, Inc
MIK
| $673K | 0.01% |
+24,860
| New | +$662K |
|
|
EPZM
639
DELISTED
Epizyme, Inc
EPZM
| $669K | 0.01% |
+35,665
| New | +$736K |
|
|
LBY
640
DELISTED
Libbey, Inc.
LBY
| $669K | 0.01% |
+16,754
| New | +$592K |
|
641
MasTec
MTZ
$26.7B
| $666K | 0.01% |
+34,532
| New | +$690K |
|
642
Strategy Inc
MSTR
$33.5B
| $652K | 0.01% |
38,540
+2,820
| +8% | +$47.6K |
|
|
TYC
643
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $650K | 0.01% |
14,415
-725,662
| -98% | -$32.3M |
|
644
AvalonBay Communities
AVB
$27.1B
| $649K | 0.01% |
+3,722
| New | +$643K |
|
645
Middleby
MIDD
$6.05B
| $649K | 0.01% |
+6,322
| New | +$642K |
|
646
Kimberly-Clark
KMB
$36.4B
| $635K | 0.01% |
5,926
-72,533
| -92% | -$8.01M |
|
|
THOR
647
DELISTED
THORATEC CORPORATION
THOR
| $632K | 0.01% |
15,084
-11,038
| -42% | -$421K |
|
|
RKT
648
DELISTED
ROCK-TENN COMPANY CL-A
RKT
| $630K | 0.01% |
9,765
-85,331
| -90% | -$5.59M |
|
649
Methanex
MEOH
$4.32B
| $627K | 0.01% |
11,703
-35,758
| -75% | -$1.79M |
|
|
FCH
650
DELISTED
Felcor Lodging Trust
FCH
| $618K | 0.01% |
53,747
-227,032
| -81% | -$2.44M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.